Other functions - preclinical in vitro and in vivo agent development assays- contract orientation meeting
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Weill Medical College Of Cornell University UEI YNT8TCJH8FQ8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,865
Award facts
- Contract value 100% obligated
- $3,865.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10065, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$211 | |
| Other Administrative Action | $0 | |
| Original award | $4,076 |
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Weill Medical College Of Cornell University by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN26100001 worth?
The government has obligated $3,865 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201200018I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award